about
Next generation sequencing of extraskeletal myxoid chondrosarcomaPotent Therapeutic Activity Against Peritoneal Dissemination and Malignant Ascites by the Novel Anti-Folate Receptor Alpha Antibody KHK2805.Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma.Dual functionality nanobioconjugates targeting intracellular bacteria in cancer cells with enhanced antimicrobial activity.Therapeutic targets and new directions for antibodies developed for ovarian cancer.Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancer.Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses.Biotinylated Chlorin and Its Zinc and Indium Complexes: Synthesis and In Vitro Biological Evaluation for Photodynamic TherapyGlycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins.Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling.Advances in ovarian cancer therapy.Combined use of EpCAM and FRα enables the high-efficiency capture of circulating tumor cells in non-small cell lung cancer.Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer.Identification of a peptide for folate receptor alpha by phage display and its tumor targeting activity in ovary cancer xenograft.Anti-Folate Receptor Alpha-Directed Antibody Therapies Restrict the Growth of Triple-negative Breast CancerRecent advances in "smart" delivery systems for extended drug release in cancer therapyOne-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
P2860
Q33591671-2895EC72-68CE-4D53-8E7F-AB745D07C65AQ33900573-7416F096-F340-46AC-A303-9AFAD40DC27BQ33914066-A7BC5337-8516-4ABA-BA3C-517329712E0EQ33918385-EFD01664-A21E-4136-BD5B-7BC33CF0A9BBQ37397674-D9599532-1158-40AC-AEF9-60EB99C31E69Q38995020-2E7EF206-BBAA-419E-B779-CA5C3597898EQ40089027-C08146B3-879D-44ED-B2DB-F8CFFACC9253Q41006050-686991F8-FA6D-48BA-827C-946D77452C73Q41207923-CAA9C660-9171-44BA-AB91-9F00DA1C623CQ47283159-07A1658E-FBF1-49A4-8AB0-CA63997F2151Q48104995-8DB7D646-67E3-46B4-B484-8121B8D550CEQ49307169-31339113-C30A-4D91-B5AB-B3D91F0B9B0AQ49367303-EE6EDF43-A957-44CD-ADBB-D60281692D94Q55008640-DA0C23E2-9668-4F1D-A78E-2D42CC26220FQ55061789-B9DC7E34-3880-4751-B9D7-FB5B7F0E90D3Q57462222-2547FC16-D812-48A8-AF47-7254443E33FBQ58735813-AEE549C8-5B57-46E1-9266-2B78E7D35A83Q59134002-E4854B58-955F-4702-A844-6F6A150C4953
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Targeting folate receptor alpha for cancer treatment
@ast
Targeting folate receptor alpha for cancer treatment
@en
Targeting folate receptor alpha for cancer treatment
@nl
type
label
Targeting folate receptor alpha for cancer treatment
@ast
Targeting folate receptor alpha for cancer treatment
@en
Targeting folate receptor alpha for cancer treatment
@nl
prefLabel
Targeting folate receptor alpha for cancer treatment
@ast
Targeting folate receptor alpha for cancer treatment
@en
Targeting folate receptor alpha for cancer treatment
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Targeting folate receptor alpha for cancer treatment
@en
P2093
Andrew N Tutt
Anthony Cheung
Debra H Josephs
Giulia Pellizzari
Heather J Bax
Jacinta Bloomfield
Kristina M Ilieva
Mariangela Figini
Silvana Canevari
P2860
P304
52553-52574
P3181
P356
10.18632/ONCOTARGET.9651
P407
P5008
P577
2016-05-27T00:00:00Z
2016-08-09T00:00:00Z